Skip to main content
. Author manuscript; available in PMC: 2015 Jul 16.
Published in final edited form as: Ann Surg Oncol. 2012 Jul 6;19(11):3335–3342. doi: 10.1245/s10434-012-2469-1

Table 1.

Patient demographics and primary tumor characteristics stratified by nodal status (n=284)

All patients Node positive Node negative p-
value

n 284 37 247

Age (years) NS
  Median (range) 55 (12 – 84) 55 (32 – 84) 55 (12 – 82)
  Mean (STD) 55.5 (14.3) 55.1 (13.3) 54.5 (14.4)
Gender (n, %) NS
  Male 151 (53.2) 21 (56.8) 130 (52.6)
  Female 133 (46.8) 16 (43.2) 117 (47.4)
Histologic type (n, %) --
  Superficial spreading 210 (73.9) 24 (64.9) 186 (75.3)
  Nodular 26 (9.2) 2 (5.4) 24 (9.7)
  Acral lentiginous 11 (3.9) 2 (5.4) 9 (3.6)
  Lentigo Maligna 9 (3.2) 2 (5.4) 7 (2.8)
  Other 6 (2.1) 1 (2.7) 5 (2.0)
  Not specified 22 (7.7) 6 (16.2) 16 (6.5)
Location (n, %) NS
  Head and Neck 48 (16.9) 9 (24.3) 39 (15.8)
  Trunk 105 (37.0) 13 (35.1) 92 (37.2)
  Extremities 131 (46.1) 15 (40.5) 116 (47.0)
Thickness (mm) NS
  Median (range) 0.85 (0.3 – 1) 0.85 (0.32 – 1) 0.85 (0.3 – 1)
  Mean (STD) 0.84 (0.13) 0.81 (0.17) 0.84 (0.13)
Ulceration (n, %)$ 17 (6.3) 5 (14.3) 12 (5.1) 0.06a
Mitotic rate (n, %)$ <0.05b
  ≥1 mm2 116 (43.1) 21 (63.6) 95 (40.3)
  <1 mm2 153 (56.9) 12 (36.4) 141 (59.7)
Clarks level (n, %)$ NS
  IV/V 172 (61.0) 20 (55.6) 152 (61.8)
  ≤III 110 (39.0) 16 (44.4) 94 (38.2)
Regression (n, %)$ 27 (10.0) 3 (8.8) 24 (10.1) NS
VGP (n, %)$ 167 (64.5) 20 (66.7) 147 (64.2) NS
TIL (n, %)$ NS
  Brisk 48 (31.6) 10 (45.5) 38 (29.2)
  Non-brisk 60 (39.5) 8 (36.4) 52 (40)
  Absent 44 (28.9) 4 (18.2) 40 (30.8)

For comparing between node positives and node negatives based on Wilcoxon, Chi-square or Fisher’s exact test.

a

Significant on chi-square and univariable logistic analysis for node positive vs. node negative (p<0.05) but not significant on multiple logistic regression analysis (p=0.06).

b

Significant on multiple logistic regression analysis for node positive vs. node negative.

$

Data unavailable or missing for ulceration in 13 cases, for mitotic rate in 15 cases, for Clarks level in 2 cases, for regression in 13 cases, for VGP in 25 cases and for TIL in 132 cases.

SLNB: sentinel lymph node biopsy, VGP: vertical growth phase, TIL: tumor infiltrating lymphocytes, NS: not significant.